Skip to main content
Guests homeVideo home
View Video
1 of 50

Still fighting to cure peanut allergies

When 12-year-old Lauren Eglite saw a "What Would You Fight For?" feature about groundbreaking peanut allergy research, she asked her father, a pharmaceutical executive and Notre Dame alumnus, if he could help.That question sparked a unique partnership with Chemical and Biomolecular Engineering Professor Basar Bilgicer, leading to the creation of Artin Immunology—a startup determined to transform Bilgicer’s research into a revolutionary drug. Unlike existing treatments, Bilgicer’s approach blocks peanut allergens before they can trigger dangerous immune overreactions, without compromising the immune system itself.Now a Notre Dame student, Lauren is fighting alongside Bilgicer to advance this research, hoping to create a safer future for millions living with peanut and other allergies.Learn more at nd.edu/stories.

More from Notre Dame Videos

1-6 of 50
Loading...